ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s stock price dropped 4.9% during trading on Tuesday . The company traded as low as $1.56 and last traded at $1.56. Approximately 271,539 shares were traded during mid-day trading, an increase of 1,236% from the average daily volume of 20,327 shares. The stock had previously closed at $1.64.
ImmunoPrecise Antibodies Price Performance
The business’s 50-day simple moving average is $1.38 and its 200 day simple moving average is $1.57.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) is a Canada-based contract research organization specializing in the discovery and development of therapeutic antibodies. The company provides a full suite of preclinical research services, from target validation and lead identification through to humanization and optimization. Its capabilities encompass hybridoma, phage display, single B cell sorting and next-generation sequencing platforms to accelerate antibody candidate selection and characterization.
ImmunoPrecise serves biopharmaceutical and biotechnology partners worldwide, offering customized solutions for projects in immuno-oncology, infectious diseases, autoimmunity and other therapeutic areas.
Featured Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
